BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28871996)

  • 21. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients.
    Lote K; Egeland T; Hager B; Stenwig B; Skullerud K; Berg-Johnsen J; Storm-Mathisen I; Hirschberg H
    J Clin Oncol; 1997 Sep; 15(9):3129-40. PubMed ID: 9294476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
    Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
    Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
    Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
    Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First experiences in treatment of low-grade glioma grade I and II with proton therapy.
    Hauswald H; Rieken S; Ecker S; Kessel KA; Herfarth K; Debus J; Combs SE
    Radiat Oncol; 2012 Nov; 7():189. PubMed ID: 23140402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and outcomes of pediatric intracranial gliomas: results from single center's 226 cases and corroborated with SEER database.
    Chen Z; Guo Z; Wang J; Cao D; Xu Y; Dong F; Wan F
    Childs Nerv Syst; 2023 Mar; 39(3):593-601. PubMed ID: 36662273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial.
    Burri SH; Prabhu RS; Sumrall AL; Brick W; Blaker BD; Heideman BE; Boltes P; Kelly R; Symanowski JT; Wiggins WF; Ashby L; Norton HJ; Judy K; Asher AL
    J Neurooncol; 2015 Jun; 123(2):259-66. PubMed ID: 25947286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
    Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
    Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival outcome and neurotoxicity in patients of high-grade gliomas treated with conformal radiation and temozolamide.
    Anand AK; Chaudhory AR; Aggarwal HN; Sachdeva PK; Negi PS; Sinha SN; Babu AG; Jena A; Rao A; Chaudhury PS
    J Cancer Res Ther; 2012; 8(1):50-6. PubMed ID: 22531514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of tumor progression after radiotherapy for low-grade gliomas: analysis from the computed tomography/magnetic resonance imaging era.
    Rudoler S; Corn BW; Werner-Wasik M; Flanders A; Preston PE; Tupchong L; Curran WJ
    Am J Clin Oncol; 1998 Feb; 21(1):23-7. PubMed ID: 9499251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of multidisciplinary management in pediatric low-grade gliomas.
    Oh KS; Hung J; Robertson PL; Garton HJ; Muraszko KM; Sandler HM; Hamstra DA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e481-8. PubMed ID: 21470783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial.
    Fitzek MM; Thornton AF; Harsh G; Rabinov JD; Munzenrider JE; Lev M; Ancukiewicz M; Bussiere M; Hedley-Whyte ET; Hochberg FH; Pardo FS
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):131-7. PubMed ID: 11516862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low grade gliomas: preliminary analysis of failure patterns among patients treated using 3D conformal external beam irradiation.
    Pu AT; Sandler HM; Radany EH; Blaivas M; Page MA; Greenberg HS; Junck L; Ross DA
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):461-6. PubMed ID: 7852107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of relapse in patients with high grade glioma receiving combined treatments including stereotactic re-irradiation for a first relapse.
    Antoni D; Jastaniah Z; Haoming QC; Gaultier C; Ahle G; Couchot J; Atlani D; Schott R; Clavier JB; Srour R; Chaussemy D; Noël G
    Cancer Radiother; 2016 Jun; 20(4):282-91. PubMed ID: 27318555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurosurgical treatment of pediatric low-grade midbrain tumors: a single consecutive institutional series of 15 patients.
    Lundar T; Due-Tønnessen BJ; Egge A; Scheie D; Brandal P; Stensvold E; Due-Tønnessen P
    J Neurosurg Pediatr; 2014 Dec; 14(6):598-603. PubMed ID: 25325421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of pediatric glioma outcomes using intraoperative MRI: a multicenter cohort study.
    Karsy M; Akbari SH; Limbrick D; Leuthardt EC; Evans J; Smyth MD; Strahle J; Leonard J; Cheshier S; Brockmeyer DL; Bollo RJ; Kestle JR; Honeycutt J; Donahue DJ; Roberts RA; Hansen DR; Riva-Cambrin J; Sutherland G; Gallagher C; Hader W; Starreveld Y; Hamilton M; Duhaime AC; Jensen RL; Chicoine MR
    J Neurooncol; 2019 Jun; 143(2):271-280. PubMed ID: 30977059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the interval from tumour surgery to radiotherapy influence survival in paediatric high grade glioma?
    Azizi AA; Paur S; Kaider A; Dieckmann K; Peyrl A; Chocholous M; Czech T; Slavc I
    Strahlenther Onkol; 2018 Jun; 194(6):552-559. PubMed ID: 29349602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.
    Bouffet E; Jakacki R; Goldman S; Hargrave D; Hawkins C; Shroff M; Hukin J; Bartels U; Foreman N; Kellie S; Hilden J; Etzl M; Wilson B; Stephens D; Tabori U; Baruchel S
    J Clin Oncol; 2012 Apr; 30(12):1358-63. PubMed ID: 22393086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
    Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
    Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma.
    Indelicato DJ; Rotondo RL; Uezono H; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Bradley JA
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):149-156. PubMed ID: 30684665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of RANO response criteria compared to clinician evaluation in WHO grade III anaplastic astrocytoma: implications for clinical trial reporting and patterns of failure.
    Kazda T; Hardie JG; Pafundi DH; Kaufmann TJ; Brinkmann DH; Laack NN
    J Neurooncol; 2015 Mar; 122(1):197-203. PubMed ID: 25577400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.